Sarah Belden publishes article in 'Expert Reviews in Molecular Medicine'

Sarah Belden (OMS III) is the first author of an article that was published in the October 2012 issue of Expert Reviews in Molecular Medicine.

The article, “MEK and RAF inhibitors for BRAF-mutated cancers,” describes the relationship between the MAPK pathway and the pathophysiology of BRAF+ melanomas.  Specifically, the article discusses how the molecular inhibition of mutations in the MAPK pathway has offered much advancement in the area of clinical melanoma research while providing a direction for future novel therapeutic approaches not only within the melanoma field, but also beyond.